Lupin Digital Health has launched a Post-Procedure Home-Based Care Guide, developed alongside the American College of ...

India's leading evidence-based Digital Therapeutics (DTx) platform, today announced the launch of its comprehensive ...

ATH434 is a Disease Modifying Drug Candidate Targeting Parkinsonian Disorders – – Topline Data Expected Mid-Year 2025 – MELBOURNE, Australia and SAN FRANCISCO, March 27, 2025 (GLOBE NEWSWIRE) -- ...

First approved therapy to address hyperphagia in individuals with Prader-Willi syndrome Management to host conference call and webcast today, March 26th, at 5:30pm ET REDWOOD CITY, Calif., March 26, ...

Life sciences data company Apheris announced that its consortium of drugmakers will contribute to OpenFold3, a Columbia ...

Ingram Micro, a business-to-business (B2B) platform company for the global technology ecosystem, today announced it has been honored by CRN®, a brand of The Channel Company, with a 5-Star Award in the ...

Coya Therapeutics, Inc. (COYA) closed the last trading session at $6.51, gaining 8.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by ...

The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.

ZINFI Technologies, Inc., a company leading the definition and creation of Unified Partner Management (UPM) solutions, today announced that its latest free guidebook, Winning with Partner Advisory ...

Rutgers faculty elected to the newest class of fellows of the American Association for the Advancement of Science (AAAS) are ...

TriSalus Life Sciences, Inc. ( NASDAQ: TLSI) Q4 2024 Earnings Conference Call March 27, 2025 8:00 AM ET Jeremy Feffer - Managing Director, LifeSci Advisors Mary Szela - President & Chief Executive ...

The Duke of Sussex set up Sentebale with Prince Seeiso of Lesotho in 2006 in honour of his late mother Princess Diana - but it has recently faced an internal boardroom battle.